AMA Update

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.


All Episodes

AMA Update 133: TSA mask mandate & updates on COVID vaccines for kids with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering state-wide mandates lifting for masks in school, and the latest developments on when a COVID vaccine will be available for kids under 5.

AMA Update 132: AMA President Gerald Harmon, MD, on fixing our health system and rebuilding trust

AMA CXO Todd Unger talks with AMA President Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares five actions we can take now to fix our ailing health care system and rebuild trust.

AMA Update 131: Reviewing a national plan to get us to a new normal with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the government’s newly released COVID response strategy and how it will take the nation out of crisis mode, the CDC’s scaled back contact tracing efforts and the U.S. Surgeon General’s renewed push to fight misinformation online.

AMA Update 130: Stephen Parodi, MD, on shifting from pandemic to endemic

AMA CXO Todd Unger talks with Stephen Parodi, MD, the executive vice president of external affairs, communications and brand at The Permanente Federation, and associate executive director for The Permanente Medical Group in Oakland, Calif., about pandemic vs. endemic and what that shift will mean for our COVID-19 response.

AMA Update 129: New CDC guidelines and tracking COVID-19 risk in your area with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering new data from CDC studies, understanding community risk and finding your local COVID-19 Community Level, as well as positive long-lasting effects of COVID booster shots.

Access the Centers for Disease Control and Prevention’s «COVID-19 by County» tracker here: https://www.cdc.gov/coronavirus/2019-ncov/your-health/covid-by-county.html

AMA Update 128: Andrea Garcia, JD, MPH, outlines data supporting vaccinated pregnant mothers pass on COVID protection

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on coronavirus treatments, including Merk’s COVID pill, as well as research outlining the positive effects of getting vaccinated during pregnancy.

AMA Update 127: The FDA on Molnupiravir and COVID-19: What physicians need to know, Part III

In part three of this three-part series, Aimee Hodowanec, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what physicians need to know about Molnupiravir as treatment for COVID-19.

AMA Update 126: Andrea Garcia, JD, MPH, discusses the latest on vaccines for children 5 and younger

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA’s pivot to wait for more data on vaccines for kids under 5, and what new data from the CDC tells us about booster shots.

AMA Update 124: The FDA on Paxlovid and COVID-19: What physicians need to know, Part II

In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.